Cargando...

Is the availability of endoscopic treatment changing the initial management of vesicoureteral reflux?

INTRODUCTION AND OBJECTIVE: The optimal management of vesicoureteral reflux (VUR) continues to be controversial. Since the approval of Dextranomer/Hyaluronic Acid copolymer implants (Dx/HA; Deflux) for endoscopic anti-reflux surgery (EARS) in 2001, the perception that EARS is less morbid than open a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Nelson, Caleb P., Copp, Hillary L., Lai, Julie, Saigal, Christopher S.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2009
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2726896/
https://ncbi.nlm.nih.gov/pubmed/19625050
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.juro.2009.05.049
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!